Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
發炎和膽固醇作為接受他汀治療患者心血管事件的預測因子:三個隨機試驗的合作分析。
Lancet 2023-07-17
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.
將此醫學文章的標題翻譯為繁體中文:將脂蛋白(a)濃度與急性冠狀動脈症候群後心血管事件風險相關聯:三種測試的比較。
Circulation 2024-04-03
Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population.
冠狀動脈疾病患者中心血管結果及高脂蛋白(a)水平:對OCEAN(a)-outcomes試驗人群的意義。
Eur Heart J Open 2023-08-29
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
具有或沒有基線動脈粥樣硬化心血管疾病患者中脂蛋白(a)與主要不良心血管事件。
J Am Coll Cardiol 2024-03-01
Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study.
腎功能改變了進行経皮冠狀動脈介入治療的患者中脂蛋白(a)與心血管結果的關聯:一項前瞻性cohort研究。
Clin Kidney J 2024-03-05
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry.
Lipoprotein(a) 作為糖尿病患者及非糖尿病患者的心血管風險因子:麻省總醫院布萊根醫學中心 Lp(a) 註冊。
Cardiovasc Diabetol 2024-07-25